51 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Bak1tm1Thsn/Bak1+ Bcl2l1tm1Dlo/Bcl2l1+ B6.Cg-Bcl2l1tm1Dlo Bak1tm1Thsn	abnormal platelet morphology	J:149205
Bak1tm1Thsn/Bak1+ Bcl2l1Plt20/Bcl2l1+ involves: 129 * BALB/c * C57BL/6	abnormal platelet morphology	J:149205
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm1Sjk involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6	abnormal B cell morphology	J:66872
	abnormal brain morphology	J:66872
	abnormal definitive hematopoiesis	J:66872
	abnormal hearing physiology	J:66872
	abnormal splenocyte physiology	J:66872
	abnormal T cell morphology	J:66872
	anemia	J:66872
	circling	J:66872
	decreased cellular sensitivity to gamma-irradiation	J:66872
	decreased physiological sensitivity to xenobiotic	J:66872
	enlarged lymph nodes	J:66872
	enlarged spleen	J:66872
	increased brain size	J:66872
	increased leukocyte cell number	J:66872
	increased lymphocyte cell number	J:66872
	increased neuron number	J:66872
	increased spleen red pulp amount	J:66872
	increased spleen white pulp amount	J:66872
	interdigital webbing	J:66872
	neonatal lethality, incomplete penetrance	J:66872
	seizures	J:66872
	thrombocytopenia	J:66872
	vagina atresia	J:66872
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm1Sjk involves: 129S1/Sv * 129X1/SvJ	normal hematopoietic system phenotype	J:141545
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm2Sjk Bcl2l1tm1.1Mam/Bcl2l1tm1.1Mam Tg(MMTV-cre)#Mam/0 involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB	normal hematopoietic system phenotype	J:141545
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm2Sjk Cd19tm1(cre)Cgn/Cd19+ involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	abnormal B cell number	J:100463
	abnormal B cell physiology	J:100463
	decreased marginal zone B cell number	J:100463
	increased B cell number	J:100463
	increased B-2 B cell number	J:100463
	increased bone marrow cell number	J:100463
	increased follicular B cell number	J:100463
	increased IgA level	J:100463
	increased IgG level	J:100463
	increased IgM level	J:100463
	increased immunoglobulin level	J:100463
	increased pre-B cell number	J:100463
	increased pro-B cell number	J:100463
	increased transitional stage B cell number	J:100463
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm2Sjk Krastm4Tyj/Kras+ involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6	increased adenocarcinoma incidence	J:125101
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm2Sjk Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA	abnormal T cell differentiation	J:100463
	arthritis	J:100463
	glomerulonephritis	J:100463
	increased anti-double stranded DNA antibody level	J:100463
	increased B cell number	J:100463
	increased leukocyte cell number	J:100463
	increased lymphocyte cell number	J:100463
	increased susceptibility to autoimmune disorder	J:100463
	premature death	J:100463
Bak1tm1Thsn/Bak1tm1Thsn Baxtm2Sjk/Baxtm2Sjk Tg(Lck-cre)1Cwi/? involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2	decreased thymocyte apoptosis	J:220951
Bak1tm1Thsn/Bak1tm1Thsn Baxtm2Sjk/Baxtm2Sjk Tg(Lck-cre)548Jxm/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA	increased regulatory T cell number	J:208318
Bak1tm1Thsn/Bak1tm1Thsn Bcl2l1tm1Dlo/Bcl2l1+ B6.Cg-Bcl2l1tm1Dlo Bak1tm1Thsn	abnormal platelet physiology	J:149205
	thrombocytosis	J:149205
Hax1tm1Jni/Hax1tm1Jni Bak1tm1Thsn/Bak1tm1Thsn involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6	premature death	J:132627
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc Bak1tm1Thsn/Bak1tm1Thsn Tg(Lck-cre)1Cwi/? involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2	normal immune system phenotype	J:220951